An action undertaken by the Executive branch of the U.S. government during the Trump administration sought to increase the availability of cost information for medical services. This initiative mandated that hospitals and insurers disclose negotiated rates for various procedures and items, aiming to empower consumers with knowledge regarding potential healthcare expenses before receiving treatment. For example, a patient considering an elective surgery could, in theory, compare prices across different providers and insurance plans.
The intended impact of this governmental directive centered on fostering competition within the healthcare market and reducing overall costs. By revealing the discrepancies in pricing across different providers, the policy aimed to incentivize facilities to offer more competitive rates to attract patients. Furthermore, proponents argued that increased visibility of healthcare costs would allow consumers to make more informed decisions, potentially leading to a reduction in unnecessary or overpriced medical services. Prior to this mandate, obtaining clear and comprehensive pricing information was often difficult, contributing to the complexity and opacity of the healthcare system.